Serum HLA-G levels in women with polycystic ovary syndrome.

Gynecol Endocrinol

Department of Obstetrics and Gynecology, School of Medicine, Pamukkale University, Denizli , Turkey .

Published: March 2015

This study was designed to determine serum human leukocyte antigen-G (HLA-G) levels and establish whether serum HLA-G level is related with insulin resistance, oxidative stress, dyslipidemia and ovarian hyperandrogenism in women with polycystic ovary syndrome (PCOS). Twenty-five patients with PCOS and 23 healthy control women were evaluated in this study. Serum HLA-G, lipid fractions, glucose, insulin, malondialdehyde (MDA), glutathione (GSH), white blood cell (WBC), sex hormone-binding globulin (SHBG) and other hormone (gonadotropins and androgens) levels were measured. The estimate of insulin resistance was calculated by homeostasis model assessment (HOMA-IR). Serum luteinizing hormone (LH), total testosterone, fasting insulin, WBC levels and LH/follicle-stimulating hormone (FSH) ratio, free androgen index (FAI) and HOMA-IR values were significantly higher in patients with PCOS compared with healthy women. However, the women with PCOS had considerably lower serum FSH, SHBG, MDA, GSH and HLA-G levels than healthy subjects. HLA-G was inversely related with HOMA-IR, FAI, LH/FSH ratio and WBC, but positively with high-density lipoprotein cholesterol. Decreased serum HLA-G level may be related with insulin resistance, ovarian hyperandrogenism and oxidative stress in women with PCOS. Nevertheless, the exact role of HLA-G in the pathogenesis of the disease remains to be elucidated.

Download full-text PDF

Source
http://dx.doi.org/10.3109/09513590.2014.982084DOI Listing

Publication Analysis

Top Keywords

serum hla-g
16
hla-g levels
12
insulin resistance
12
women polycystic
8
polycystic ovary
8
ovary syndrome
8
hla-g level
8
level insulin
8
oxidative stress
8
ovarian hyperandrogenism
8

Similar Publications

Background: Human leukocyte antigen-G (HLA-G) is a cancer-associated immune checkpoint protein implicated in tumor-driven immune escape mechanisms. This study was undertaken to determine genetic variations at the 3'-UTR of the HLA-G gene that may alter its expression, identify risk alleles and genotypes for their association with hepatocellular carcinoma (HCC), and treatment responses in the Indian population.

Objectives: Case-control genetic association study of HLA-G gene UTR polymorphisms with HCC and response to locoregional therapy (LRT).

View Article and Find Full Text PDF

Background: Human leukocyte antigen G (HLA-G) is an immune checkpoint molecule with immunosuppressive and anti-inflammatory activities. It belongs to class I non-classical major histocompatibility complex molecules and has been upregulated in various cancer types. In bladder cancer (BC) tumors, the association of HLA-G with cancer progression has to be explained.

View Article and Find Full Text PDF

Systemic lupus erythematosus is a chronic autoimmune disease that has been associated with human leukocyte antigen G (HLA-G) in previous studies on immunological diseases. This study aimed to investigate the association between three HLA-G gene polymorphisms (rs1632947, rs1233334, and rs371194629) and their impact on HLA-G mRNA expression and soluble HLA-G levels in serum. Genotyping was performed using TaqMan probe PCR.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how variants in the HLA-G gene and soluble HLA-G (sHLA-G) levels may relate to susceptibility to COVID-19 in 65 patients compared to 67 healthy controls.
  • Key findings indicate that the 14-bp INS/DEL polymorphism increases the likelihood of experiencing COVID-19 symptoms, while the +3196C/G polymorphism appears protective.
  • Additionally, higher serum levels of sHLA-G were found in COVID-19 patients, suggesting that these genetic factors could inform on immune responses and help identify individuals at higher risk or needing targeted treatments.
View Article and Find Full Text PDF

Background: Despite the advances of therapies, multiple myeloma (MM) remains an incurable hematological cancer that most patients experience relapse. Tumor angiogenesis is strongly correlated with cancer relapse. Human leukocyte antigen G (HLA-G) has been known as a molecule to suppress angiogenesis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!